New drugs are coming to market at sky-high prices

Wall Street Journal

9 March 2023 - Trend follows rising pressure on companies to rein in repeat or annual price hikes for older drugs/

A new Amgen lung cancer treatment, Lumykras, carried a hefty price tag when it came out in 2021; $17,900 per patient monthly.

Read Wall Street Journal article (subscription required) 

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Cancer , Medicine , US , Pricing , Affordability